Company Birzeit Pharmaceuticals Company Palestine Exchange
Equities
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- | - |
02-25 | Birzeit Pharmaceuticals Company Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
01-09 | What does the Gotham City report say about Grifols? | RE |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medicines
100.0
%
| 47 | 100.0 % | 43 | 100.0 % | -8.31% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Palestine
100.0
%
| 47 | 100.0 % | 43 | 100.0 % | -8.31% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Talal Nasereddin
CEO | Chief Executive Officer | 74 | 31/03/84 |
Director of Finance/CFO | - | 14/11/84 | |
Chief Tech/Sci/R&D Officer | - | 31/01/97 | |
Chief Tech/Sci/R&D Officer | 71 | 03/04/77 | |
Chief Administrative Officer | 54 | 31/12/91 | |
Comptroller/Controller/Auditor | - | 08/09/98 | |
Human Resources Officer | - | 05/01/09 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 31/12/20 | |
Chief Administrative Officer | 54 | 31/12/91 | |
Talal Nasereddin
CEO | Chief Executive Officer | 74 | 31/03/84 |
Director/Board Member | - | 29/04/84 | |
Director/Board Member | - | 29/07/90 | |
Director/Board Member | - | 27/05/92 | |
Director/Board Member | - | 17/04/11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,764,898 | 28,654,287 ( 73.92 %) | 0 | 73.92 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+21.88% | 43.92B | |
+24.56% | 23.09B | |
+18.99% | 15.35B | |
+14.34% | 13.61B | |
+46.38% | 12.02B | |
-10.14% | 7B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.07% | 5.6B |
- Stock Market
- Equities
- BPC Stock
- Stock
- Company Birzeit Pharmaceuticals Company